Daily non-political popular news in brief.
Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders
10-30-2006 · EurekAlert!Saint Louis University scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.
Read more »
Keywords: making, headway, hepatitis, slu, study, shows, drug, combo, effective, nonresponders, hepatiti, show, nonresponder
« Previous | Next »
Similar news on "Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders":
- Making headway against hepatitis C: SLU study shows new drug combo effective in non-responders
10-30-2006 · EurekAlert!
Saint Louis University scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.
Similar news · Read more »
- Bioabsorbable stent shows excellent performance
03-24-2007 · EurekAlert!
The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
Similar news · Read more »
- New drug shows promise for treating epileptic seizures
04-05-2007 · EurekAlert!
A new study appearing in the latest issue of Epilepsia shows that a new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications. A once-daily dose was shown to be most effective, offering patients added convenience as current treatments can involve several doses per day.
Similar news · Read more »
- Knocking out survival protein could aid leukemia treatment
04-20-2007 · EurekAlert!
An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows. The findings suggest that a drug that can block this "survival protein" might on its own be an effective therapy.
Similar news · Read more »
- Penn's Abramson Cancer Center part of major phase III study for myeloma
11-21-2007 · EurekAlert!
Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
Similar news · Read more »
- Worried about prostate cancer? Tomato-broccoli combo shown to be effective
01-15-2007 · EurekAlert!
A new University of Illinois study shows that tomatoes and broccoli -- two vegetables known for their cancer-fighting qualities -- are better at shrinking prostate tumors when both are part of the daily diet than when they're eaten alone.
Similar news · Read more »
- Dual renin system blocking drug combo provides additional blood pressure-lowering effects
03-26-2007 · EurekAlert!
A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, according to a study presented today at the American College of Cardiology’s 56th Annual Scientific Session.
Similar news · Read more »
- Study shows drug effective in treating, preventing breast cancer
11-01-2007 · EurekAlert!
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
Similar news · Read more »
- Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
- Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
11-01-2007 · EurekAlert!
A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
Similar news · Read more »
